Pantophysin is a protein that plays a role in a particular cellular function, activators of this protein would be compounds that bind to and increase its activity. The study of such activators would start with a comprehensive understanding of the pantophysin structure, which would likely involve using advanced analytical techniques like X-ray crystallography, cryo-electron microscopy, or nuclear magnetic resonance (NMR) spectroscopy. These methods would reveal the three-dimensional architecture of pantophysin, including binding sites for activators. Activators could function by directly engaging with the active site of the protein, potentiating its action, or they could interact with allosteric sites to induce a conformational change that results in an increase in the protein's natural activity. The design of these molecules would be based on this structural information, and they could be tailored to influence the function of pantophysin in a specific way.
Once candidate activators are synthesized, they would undergo a series of in vitro assays to assess their ability to enhance the activity of pantophysin. These assays would typically measure changes in the protein's function, such as binding affinity for its substrates or partners, or any enzymatic activity it may possess. Furthermore, the interaction between pantophysin and its activators could be quantified using biophysical techniques to determine binding constants, kinetics, and the specificity of the interaction. Techniques like isothermal titration calorimetry, surface plasmon resonance, and fluorescence anisotropy would be invaluable in characterizing these interactions. In this iterative process, the chemical structure of the activators could be refined to optimize their efficacy and selectivity for pantophysin. This detailed research would contribute to a deeper understanding of the protein's role in cellular processes and how its function can be modulated at a molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cysteamine | 60-23-1 | sc-217991 sc-217991A sc-217991B | 5 g 25 g 50 g | $89.00 $238.00 $442.00 | 1 | |
Cysteamine can deplete CoA stores, potentially upregulating enzymes like pantothenate kinase to compensate for reduced CoA levels. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
NAD+ is involved in energy metabolism and might influence the expression of enzymes in related biosynthetic pathways, including CoA synthesis. | ||||||
α-Ketoglutaric Acid | 328-50-7 | sc-208504 sc-208504A sc-208504B sc-208504C sc-208504D sc-208504E sc-208504F | 25 g 100 g 250 g 500 g 1 kg 5 kg 16 kg | $33.00 $43.00 $63.00 $110.00 $188.00 $738.00 $2091.00 | 2 | |
Alpha-ketoglutarate is a key metabolite in the TCA cycle, and its levels can reflect metabolic status, potentially influencing CoA biosynthetic enzyme expression. | ||||||
Citric Acid, Anhydrous | 77-92-9 | sc-211113 sc-211113A sc-211113B sc-211113C sc-211113D | 500 g 1 kg 5 kg 10 kg 25 kg | $50.00 $110.00 $145.00 $248.00 $598.00 | 1 | |
Citrate accumulates when energy supplies exceed demand, and it might act as a signal to adjust the expression of metabolic enzymes, including those in CoA biosynthesis. | ||||||
Adenosine phosphate(Vitamin B8) | 61-19-8 | sc-278678 sc-278678A | 50 g 100 g | $160.00 $240.00 | ||
AMP indicates low energy status and can activate AMP-activated protein kinase (AMPK), which can alter the expression of metabolic genes. | ||||||
Acetyl coenzyme A trisodium salt | 102029-73-2 | sc-210745 sc-210745A sc-210745B | 1 mg 5 mg 1 g | $47.00 $92.00 $5826.00 | 3 | |
Acetyl-CoA levels can signal the cellular metabolic state and might regulate enzymes involved in its own synthesis pathway. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine is known to activate AMPK, potentially influencing the expression of genes involved in metabolism, including CoA biosynthesis. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate activates peroxisome proliferator-activated receptor alpha (PPARα), which can influence lipid metabolism and might affect CoA enzyme expression. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone is a PPARγ agonist that can alter the expression of various metabolic genes, potentially including those in the CoA biosynthetic pathway. | ||||||